Perimenopause Hormone Testing: Which Tests You Actually Need

Know which hormone tests matter during perimenopause. FSH, AMH, estradiol, and more — when to test, what results mean, and how to track changes over time.

When you suspect perimenopause is affecting your fertility, the right hormone tests can transform uncertainty into a clear clinical picture. But perimenopause testing isn't straightforward—hormone levels fluctuate dramatically during transition, single tests can be misleading, and not all tests are equally useful at every stage. This guide cuts through the confusion to tell you exactly which tests you need, when to take them, and how to interpret results that your GP might not fully explain.

The Core Perimenopause Panel

These are the essential tests for assessing where you stand in the perimenopause transition and what it means for fertility:

  • AMH (Anti-Müllerian Hormone): The most reliable single marker of ovarian reserve. Unlike FSH, AMH doesn't fluctuate much within a cycle. Values below 1.0 ng/mL suggest significantly diminished reserve
  • FSH (Follicle-Stimulating Hormone): Must be tested on cycle day 2-4 for accuracy. Rising FSH (>10 mIU/mL) indicates your pituitary is working harder to stimulate fewer remaining follicles
  • Estradiol (E2): Test alongside FSH on day 2-4. High early-cycle estradiol (>80 pg/mL) can mask elevated FSH, giving a falsely reassuring picture
  • Antral Follicle Count (AFC): Ultrasound-based count of small follicles visible in both ovaries. Combined with AMH, this gives the most accurate ovarian reserve assessment
  • Inhibin B: Declining inhibin B is an early marker of reduced ovarian reserve, sometimes dropping before FSH rises. Not always included in standard panels—ask for it

When to Test: Timing Matters

Hormone levels during perimenopause are a moving target. Testing strategy matters as much as the tests themselves:

  • FSH and Estradiol: Always test on cycle day 2-4 (early follicular phase). If cycles are irregular, test as soon as possible after bleeding starts
  • AMH: Can be tested any day of the cycle—it's relatively stable. However, serial testing every 6-12 months tracks the rate of decline
  • AFC: Best assessed during the early follicular phase (day 2-5) when follicles are smallest and most accurately counted
  • Repeat testing: A single abnormal result doesn't confirm perimenopause. Test at least twice, 2-3 months apart, to confirm a trend
  • Track the trajectory: A declining trend matters more than any single number. AMH dropping from 2.0 to 1.2 in 12 months suggests rapid decline even though 1.2 is still 'normal'

Keep a record of all your test results with dates. Trends over time tell a much more accurate story than any individual snapshot. Our Peri-Fertility Analyzer tracks your results and maps them to STRAW+10 stages automatically.

Additional Tests Worth Considering

Beyond the core panel, these tests can provide additional context for perimenopause-related fertility decisions:

  • Thyroid panel (TSH, free T3, free T4): Thyroid dysfunction is more common during perimenopause and can independently impair fertility
  • Vitamin D: Low vitamin D is associated with lower AMH levels and poorer IVF outcomes. Easily correctable if deficient
  • DHEA-S: Some reproductive endocrinologists use DHEA supplementation for diminished ovarian reserve. Baseline testing guides this decision
  • Prolactin: Elevated prolactin can suppress ovulation and mimic perimenopause symptoms. Worth ruling out
  • Genetic testing (FMR1): If you're under 40 with signs of early perimenopause, FMR1 premutation carrier screening can explain premature ovarian insufficiency

Interpreting Your Results

Perimenopause hormone results rarely give a clean, simple answer. Here's how to read the picture they paint together:

  • AMH < 1.0 + FSH > 10: Strong evidence of diminished reserve. Consider fertility preservation or treatment within 6-12 months
  • Normal AMH + elevated FSH: Early discordance—your reserve may be adequate now, but the trend is concerning. Retest in 3 months
  • Low AMH + normal FSH: AMH declines first. You may still be ovulating regularly, but egg quantity is limited. Don't delay action based on 'normal' FSH alone
  • All markers normal but symptoms present: Perimenopause can begin with symptoms before lab values shift measurably. Continue monitoring every 6 months
  • Very low AMH (<0.3) + very high FSH (>25): Late transition. Own-egg options are limited. Discuss donor eggs as a parallel track

Key takeaways

  • AMH is the most reliable single test for ovarian reserve—it doesn't fluctuate within a cycle
  • Always test FSH and estradiol together on cycle day 2-4; high estradiol can mask elevated FSH
  • Trends over time matter more than any single test result—track your numbers every 6-12 months
  • Discordant results (e.g., low AMH but normal FSH) require careful interpretation—get specialist input
  • Don't wait for 'abnormal' lab results to act—if symptoms are present, the clock is already ticking

Frequently asked questions

Can my GP run perimenopause hormone tests?

Yes, GPs can order FSH, estradiol, and AMH tests. However, interpretation for fertility purposes is best done by a reproductive endocrinologist who understands the nuances of perimenopause staging.

How often should I retest during perimenopause?

Every 6-12 months if you're in early perimenopause, or every 3-6 months if tests show rapid decline. Serial testing reveals the speed of your transition, which is crucial for planning.

Are at-home hormone tests accurate for perimenopause?

At-home AMH and FSH tests can provide useful screening data, but they have wider error margins than lab tests. They're a reasonable starting point, but confirm any concerning results with a clinical lab draw.